BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26707189)

  • 1. Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancer.
    Yen MC; Shih YC; Hsu YL; Lin ES; Lin YS; Tsai EM; Ho YW; Hou MF; Kuo PL
    Oncol Rep; 2016 Mar; 35(3):1356-64. PubMed ID: 26707189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model.
    Hwang JY; Park JH; Kim MJ; Kim WJ; Ha KT; Choi BT; Lee SY; Shin HK
    Cancer Lett; 2019 Feb; 443():25-33. PubMed ID: 30503550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
    Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
    Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway.
    Che S; Sun T; Wang J; Jiao Y; Wang C; Meng Q; Qi W; Yan Z
    Tumour Biol; 2015 Sep; 36(9):6805-11. PubMed ID: 25840690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer.
    La Manna S; Lee E; Ouzounova M; Di Natale C; Novellino E; Merlino A; Korkaya H; Marasco D
    Int J Cancer; 2018 Nov; 143(9):2177-2186. PubMed ID: 29752723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-concentration atropine induces corneal epithelial cell apoptosis via miR-30c-1/SOCS3.
    Chen XJ; Hu P; Yi S
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1113-1122. PubMed ID: 36156413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
    Park JH; Kim MJ; Kim WJ; Kwon KD; Ha KT; Choi BT; Lee SY; Shin HK
    Cancer Lett; 2020 May; 478():71-81. PubMed ID: 32173479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
    Lin XM; Chen H; Zhan XL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Sesquiterpenoid from Farfarae Flos Induces Apoptosis of MDA-MB-231 Human Breast Cancer Cells through Inhibition of JAK-STAT3 Signaling.
    Jang H; Ko H; Song K; Kim YS
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31337063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
    Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9286-9294. PubMed ID: 31773696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis.
    Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J
    Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte-derived exosomal miR-30c-5p promotes ovarian angiogenesis in polycystic ovary syndrome via the SOCS3/STAT3/VEGFA pathway.
    Hu J; Lin F; Yin Y; Shang Y; Xiao Z; Xu W
    J Steroid Biochem Mol Biol; 2023 Jun; 230():106278. PubMed ID: 36870372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy.
    Zhang W; Yu W; Cai G; Zhu J; Zhang C; Li S; Guo J; Yin G; Chen C; Kong L
    Cell Death Dis; 2018 Oct; 9(11):1098. PubMed ID: 30368518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperlongumine inhibits the progression of osteosarcoma by downregulating the SOCS3/JAK2/STAT3 pathway via miR-30d-5p.
    Hu Y; Luo X; Zhou J; Chen S; Gong M; Deng Y; Zhang H
    Life Sci; 2021 Jul; 277():119501. PubMed ID: 33862108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
    Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
    Wang S; Chen X; Tang M
    Oncol Rep; 2014 Dec; 32(6):2824-30. PubMed ID: 25220761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
    Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
    Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
    Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.